Genetic events drive ALL subtypeJanuary 14, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Interventions can ease insomnia in cancer patientsJanuary 14, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Antipsychotic drug is active against T-ALLJanuary 13, 2014Leukemia, Myelodysplasia, TransplantationALL
Deaths from leukemia, NHL declining in the UKJanuary 13, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
AML scoring system could optimize treatmentJanuary 10, 2014Leukemia, Myelodysplasia, TransplantationAML
Leukemia is leading cause of cancer death among young AmericansJanuary 9, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Out-of-pocket costs hinder adherence to imatinibJanuary 8, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
Internists may be ill-equipped to care for childhood cancer survivorsJanuary 8, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
Ponatinib may be returning to market with new safety measuresDecember 21, 2013Leukemia, Myelodysplasia, Transplantation
Nilotinib beats imatinib in newly diagnosed CMLDecember 20, 2013Leukemia, Myelodysplasia, Transplantation
Phase 3 ponatinib trial stopped due to adverse eventsOctober 19, 2013Leukemia, Myelodysplasia, Transplantation
Drug gets orphan designation for MDSOctober 4, 2013AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Company suspends enrollment in drug trialsFebruary 21, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma